or
forgot password
  • cancer clinical trials in bryn mawr, PA

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Prostate Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Endometrial Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Prostate Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Brain and Central Nervous System Tumors
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Endometrial Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Center for Urologic Care of the Main Line
    Bryn Mawr, Pennsylvania 19010
    Prostate Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    Urology Health Specialists - Bryn Mawr
    Bryn Mawr, Pennsylvania 19010
    Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Couple-Focused Intervention for Breast Cancer Patients
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Breast Cancer
    Depression Screening in Patients Undergoing Radiation Therapy For Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Depression, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Kidney Cancer
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Bryn Mawr Hospital
    Bryn Mawr, Pennsylvania 19010
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer